These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 10953963)

  • 1. Early detection of genetic hemochromatosis: should all young adults be offered the genetic test?
    Worwood M
    Genet Test; 2000; 4(2):219-28. PubMed ID: 10953963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The S65C mutation in Spain. Implications for iron overload screening.
    Remacha AF; Barceló MJ; Sardà MP; Blesa I; Altés A; Baiget M
    Haematologica; 2000 Dec; 85(12):1324-5. PubMed ID: 11114141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population screening for hemochromatosis.
    Adams PC
    Hepatology; 1999 Apr; 29(4):1324-7. PubMed ID: 10094982
    [No Abstract]   [Full Text] [Related]  

  • 4. Transferrin saturation phenotype and HFE genotype screening for hemochromatosis and primary iron overload: predictions from a model based on national, racial, and ethnic group composition in central Alabama.
    Barton JC; Acton RT
    Genet Test; 2000; 4(2):199-206. PubMed ID: 10953960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases?
    Adams PC
    Mol Genet Metab; 2000; 71(1-2):81-6. PubMed ID: 11001800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
    Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
    Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of haemochromatosis since the discovery of the HFE gene: a European experience.
    Br J Haematol; 2000 Jan; 108(1):31-9. PubMed ID: 10651721
    [No Abstract]   [Full Text] [Related]  

  • 9. HFE mutation analysis in patients with hepatitis C virus with positive screening for iron overload.
    Remacha AF; Carrasco M; Sardá MP; Barceló MJ; Baiget M
    Haematologica; 1999 Mar; 84(3):284-5. PubMed ID: 10189401
    [No Abstract]   [Full Text] [Related]  

  • 10. Cloning of the hereditary hemochromatosis gene: implications for pathogenesis, diagnosis, and screening.
    Himmelmann A; Fehr J
    J Lab Clin Med; 1999 Mar; 133(3):229-36. PubMed ID: 10072254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Gomez PS; Parks S; Ries R; Tran TC; Gomez PF; Press RD
    Nat Genet; 1999 Nov; 23(3):272. PubMed ID: 10545944
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemochromatosis, a public health problem].
    Aguilar Martinez P
    Soins; 2007 Jun; (716):34-5. PubMed ID: 17718029
    [No Abstract]   [Full Text] [Related]  

  • 13. Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors.
    Adams PC; Kertesz AE; McLaren CE; Barr R; Bamford A; Chakrabarti S
    Hepatology; 2000 May; 31(5):1160-4. PubMed ID: 10796893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemochromatosis: pathological or beneficial.
    Worwood M
    Schweiz Med Wochenschr; 1998 Dec; 128(49):1925-35. PubMed ID: 9887470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemochromatosis and HLA-H.
    Jazwinska EC; Cullen LM; Busfield F; Pyper WR; Webb SI; Powell LW; Morris CP; Walsh TP
    Nat Genet; 1996 Nov; 14(3):249-51. PubMed ID: 8896549
    [No Abstract]   [Full Text] [Related]  

  • 16. Hereditary hemochromatosis: gene discovery and its implications for population-based screening.
    Burke W; Thomson E; Khoury MJ; McDonnell SM; Press N; Adams PC; Barton JC; Beutler E; Brittenham G; Buchanan A; Clayton EW; Cogswell ME; Meslin EM; Motulsky AG; Powell LW; Sigal E; Wilfond BS; Collins FS
    JAMA; 1998 Jul; 280(2):172-8. PubMed ID: 9669792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary hemochromatosis: recent advances in molecular genetics and clinical management.
    Camaschella C; Piperno A
    Haematologica; 1997; 82(1):77-84. PubMed ID: 9107091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA testing for haemochromatosis: diagnostic, predictive and screening implications.
    Trent RJ; Le H; Yu B; Young G; Bowden DK
    Pathology; 2000 Nov; 32(4):274-9. PubMed ID: 11186424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of the C282Y mutation in Brittany: penetrance of genetic hemochromatosis?
    Jouanolle AM; Fergelot P; Raoul ML; Gandon G; Roussey M; Deugnier Y; Feingold J; Le Gall JY; David V
    Ann Genet; 1998; 41(4):195-8. PubMed ID: 9881181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary hemochromatosis genetic testing of at-risk children: what is the appropriate age?
    Delatycki MB; Powell LW; Allen KJ
    Genet Test; 2004; 8(2):98-103. PubMed ID: 15345104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.